Literature DB >> 22595719

Pediatric malignancies: neuroblastoma, Wilm's tumor, hepatoblastoma, rhabdomyosarcoma, and sacroccygeal teratoma.

Katherine P Davenport1, Felix C Blanco, Anthony D Sandler.   

Abstract

Common pediatric malignancies are reviewed: neuroblastoma, Wilms tumor, hepatoblastoma, rhabdomyosarcoma, and sacrococcygeal teratoma. Elements of presentation, diagnosis, staging, treatment, and longterm prognosis are discussed, with particular attention to surgical management.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2012        PMID： 22595719     DOI： 10.1016/j.suc.2012.03.004

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN： 0039-6109            Impact factor:   2.741


  13 in total

1.  Wilms tumor-suppressing peptide inhibits proliferation and induces apoptosis of Wilms tumor cells in vitro and in vivo.

Authors:  Wei Zhao; Juan Li; Ping Li; Fei Guo; Pengfei Gao; Junjie Zhang; Zechen Yan; Lei Wang; Da Zhang; Pan Qin; Guoqiang Zhao; Jiaxiang Wang
Journal:  J Cancer Res Clin Oncol       Date:  2019-08-28       Impact factor: 4.553

2.  Nasopharyngeal nephroblastoma in a 3-month-old Boer goat.

Authors:  Jillian M Athey; Laura E Rice; Aja B Harvey; Kevin E Washburn; Aline Rodrigues-Hoffmann
Journal:  J Vet Diagn Invest       Date:  2020-10-28       Impact factor: 1.279

3.  Opioid growth factor (OGF) for hepatoblastoma: a novel non-toxic treatment.

Authors:  Moshe Rogosnitzky; Milton J Finegold; Patricia J McLaughlin; Ian S Zagon
Journal:  Invest New Drugs       Date:  2012-12-30       Impact factor: 3.850

4.  Trans-oral approach for the management of a C2 neuroblastoma.

Authors:  K M I Salem; J Visser; N A Quraishi
Journal:  Eur Spine J       Date:  2014-02-19       Impact factor: 3.134

5.  Predictors of survival and incidence of hepatoblastoma in the paediatric population.

Authors:  Bassan J Allan; Punam P Parikh; Sofia Diaz; Eduardo A Perez; Holly L Neville; Juan E Sola
Journal:  HPB (Oxford)       Date:  2013-04-22       Impact factor: 3.647

6.  Molecular Mechanism of the Cell Death Induced by the Histone Deacetylase Pan Inhibitor LBH589 (Panobinostat) in Wilms Tumor Cells.

Authors:  Tao Yan-Fang; Li Zhi-Heng; Xu Li-Xiao; Fang Fang; Lu Jun; Li Gang; Cao Lan; Wang Na-Na; Du Xiao-Juan; Sun Li-Chao; Zhao Wen-Li; Xiao Pei-Fang; Zhao He; Su Guang-Hao; Li Yan-Hong; Li Yi-Ping; Xu Yun-Yun; Zhou Hui-Ting; Wu Yi; Jin Mei-Fang; Liu Lin; Ni Jian; Hu Shao-Yan; Zhu Xue-Ming; Feng Xing; Wang Jian; Pan Jian
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

Review 7.  Pediatric genitourinary oncology.

Authors:  Francisco Tibor Dénes; Ricardo Jordão Duarte; Lílian Maria Cristófani; Roberto Iglesias Lopes
Journal:  Front Pediatr       Date:  2013-12-16       Impact factor: 3.418

8.  Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells.

Authors:  Yan-Fang Tao; Jun Lu; Xiao-Juan Du; Li-Chao Sun; Xuan Zhao; Liang Peng; Lan Cao; Pei-Fang Xiao; Li Pang; Dong Wu; Na Wang; Xing Feng; Yan-Hong Li; Jian Ni; Jian Wang; Jian Pan
Journal:  BMC Cancer       Date:  2012-12-26       Impact factor: 4.638

9.  Sacrococcygeal Teratoma With Multiple Recurrences by Intradural Extension in the Neonate: A Common Neonatal Mass With an Unusual Course.

Authors:  Allison Spencer Bechtel; Cynthia A Gauger
Journal:  Glob Pediatr Health       Date:  2014-11-25

10.  Stage IV Wilms Tumor Treated by Korean Medicine, Hyperthermia and Thymosin-α1: A Case Report.

Authors:  Donghyun Lee; Sung Su Kim; Shin Seong; Wonjun Cho; Hyejin Yu
Journal:  Case Rep Oncol       Date:  2016-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.